Therapeutic effect of nerve growth factor on canine cerebral infarction evaluated by MRI

Yong Wang; Hui Zhang; Zhe Wang; Huaijun Liu; Xin Tian; Jian Yu; Chaoxu Chen

doi:10.18632/oncotarget.23345

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Therapeutic effect of nerve growth factor on canine cerebral infarction evaluated by MRI

Yong Wang _, Hui Zhang, Zhe Wang, Huaijun Liu, Xin Tian, Jian Yu and Chaoxu Chen

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2018; 9:3741-3751. https://doi.org/10.18632/oncotarget.23345

Metrics: PDF 1086 views | HTML 1844 views | ?

Abstract

Yong Wang1, Hui Zhang2, Zhe Wang3, Huaijun Liu1, Xin Tian1, Jian Yu1 and Chaoxu Chen1

1Department of Radiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province 050000, China

2Department of Radiology, Hebei General Hospital, Shijiazhuang, Hebei Province 050051, China

3Department of Computer Science, Clinical College of Hebei Medical University, Shijiazhuang, Hebei Province 050031, China

Correspondence to:

Yong Wang, email: [email protected]

Keywords: nerve growth factor; canine middle cerebral artery occlusion; magnetic resonance imaging; diffusion-weighted imaging; perfusion-weighted imaging

Received: September 22, 2017 Accepted: November 16, 2017 Published: December 16, 2017

ABSTRACT

To explore therapeutic effect of nerve growth factor (NGF) on cerebral infarction by establishing canine middle cerebral artery occlusion (MCAO) infarct model. The magnetic resonance imaging (MRI) technology was used to study effects of NGF on cerebral infarction, and the results of MRI indexes (such as diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI)) were compared with the results of pathology, cell biology and molecular biology. The clinical manifestations of the canine infarction model treated by NGF were significantly improved within 7 days compared with control group. The therapeutic evaluation of NGF effect could be determine by canine cerebral infarction treated by NGF within 6 hours according to DWI and PWI. From 6 hours to 7 days, therapeutic evaluation of NGF could be determine by T1WI, T2WI and FLAIR. DWI and PWI could find the change of cerebral ischemia at the early stage, provide advantages for qualitative diagnosis of early-stage cerebral infarction and observation of efficacy in early treatment, initially showing that their great potential for NGF role on cerebral ischemia and mechanism.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23345

Publication Alerts

Research Papers:

Therapeutic effect of nerve growth factor on canine cerebral infarction evaluated by MRI

Abstract